Reports for APOTEX INC

Formerly known as AA PHARMA INC

Company Name
APOTEX INC

Shortage reports

Actual shortage:

220 (7%)

Anticipated shortage:

0 (0%)

Avoided shortage:

10 (0%)

Resolved:

3124 (93%)

3354

Discontinuation Reports

To be discontinued:

26 (7%)

Discontinued:

343 (93%)

Reversed:

0 (0%)

369

145 (4%)

73 (30%)

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
APO-OLANZAPINE 10.0MG TABLET Resolved 2020-10-07 2020-12-17 125815
APO-OLANZAPINE 2.5MG TABLET Resolved 2023-11-06 2024-03-01 209363
APO-OLANZAPINE 10.0MG TABLET Resolved 2019-02-24 2019-03-29 76729
APO-OLANZAPINE 10.0MG TABLET Resolved 2017-11-07 2018-01-11 28564
APO-OLANZAPINE 2.5MG TABLET Resolved 2022-10-28 2022-12-09 172901
APO-OLANZAPINE 7.5MG TABLET Resolved 2020-07-29 2020-12-17 121337
APO-OLANZAPINE 20.0MG TABLET Resolved 2020-07-29 2020-12-17 121334
APO-OLANZAPINE 7.5MG TABLET Resolved 2023-07-27 2023-09-28 200180
APO-OLANZAPINE 10MG TABLET Resolved 2022-10-07 2022-12-05 171422
APO-OLANZAPINE 10.0MG TABLET Resolved 2017-08-23 2017-10-03 20113
APO-OLANZAPINE 7.5MG TABLET Resolved 2022-04-01 2022-04-29 157701
APO-OLANZAPINE 20.0MG TABLET Resolved 2018-02-01 2018-05-25 37997
APO-OLANZAPINE 20.0MG TABLET Resolved 2019-05-15 2019-06-24 84128
APO-OLANZAPINE 15.0MG TABLET Resolved 2017-12-14 2018-04-05 32818
APO-OLANZAPINE 7.5MG TABLET Resolved 2022-10-17 2022-12-05 171886
APO-OLANZAPINE 10MG TABLET Resolved 2023-07-13 2023-09-15 198518
APO-OLANZAPINE 5.0MG TABLET Resolved 2020-02-13 2020-06-02 106006
APO-OLANZAPINE ODT 10MG TABLET (ORALLY DISINTEGRATING) Resolved 2020-04-13 2020-12-21 111928
APO-OLANZAPINE ODT 20MG TABLET (ORALLY DISINTEGRATING) Resolved 2023-07-21 2023-11-06 199515
APO-OLANZAPINE ODT 5MG TABLET (ORALLY DISINTEGRATING) Resolved 2023-04-27 2023-06-02 190862
Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
APO-HYDROMORPHONE CR 4.5MG CAPSULE (EXTENDED RELEASE) Discontinued 2020-04-04 2020-04-04 110974
APO-HYDROMORPHONE CR 18MG CAPSULE (EXTENDED RELEASE) Discontinued 2020-04-04 2020-04-04 110965
APO-HYDROMORPHONE CR 3MG CAPSULE (EXTENDED RELEASE) Discontinued 2020-04-04 2020-04-04 110956
APO-HYDROMORPHONE CR 6MG CAPSULE (EXTENDED RELEASE) Discontinued 2020-04-04 2020-04-04 110959
APO-HYDROMORPHONE CR 12MG CAPSULE (EXTENDED RELEASE) Discontinued 2020-04-04 2020-04-04 110962
APO-HYDROMORPHONE CR 9MG CAPSULE (EXTENDED RELEASE) Discontinued 2020-04-04 2020-04-04 110977
APO-HYDROXYQUINE 200MG TABLET Discontinued 2018-09-07 2018-10-05 60524
APO-IMIQUIMOD Discontinued 2019-11-26 2019-11-26 99672
APO-IRBESARTAN 150MG TABLET Discontinued 2018-09-07 2018-12-28 60536
APO-IRBESARTAN 150MG TABLET Discontinued 2019-01-04 2019-01-04 71234
APO-IRBESARTAN 75MG TABLET Discontinued 2019-01-04 2019-01-04 71231
APO-IRBESARTAN 300MG TABLET Discontinued 2019-01-04 2019-01-04 71237
APO-IRBESARTAN 300MG TABLET Discontinued 2018-09-07 2018-09-15 60539
APO-IRBESARTAN/HCTZ Discontinued 2018-09-07 2018-09-15 60548
APO-IRBESARTAN/HCTZ 25MG 300MG TABLET Discontinued 2018-02-23 2018-09-15 40769
APO-IRBESARTAN/HCTZ 25MG 300MG TABLET Discontinued 2018-02-23 2018-09-15 40766
APO-IRBESARTAN/HCTZ Discontinued 2018-02-23 2018-07-17 40763
APO-IRBESARTAN/HCTZ 12.5MG 150MG TABLET Discontinued 2018-02-23 2018-02-23 40757
APO-IRBESARTAN/HCTZ 12.5MG 150MG TABLET Discontinued 2018-02-23 2018-07-17 40760
APO-LAMIVUDINE 150MG TABLET Discontinued 2018-09-07 2019-07-13 60557